Marshall Wace North America’s KalVista Pharmaceuticals KALV Stock Holding History

Marshall Wace North America’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell
2021 Q2	$530K	Sell
2021 Q1	$2.52M	Buy
2019 Q2	–	Sell
2019 Q1	$175K	Buy